首页> 外文学位 >Adenovirus-p53 gene therapy in nasopharyngeal carcinoma xenografts.
【24h】

Adenovirus-p53 gene therapy in nasopharyngeal carcinoma xenografts.

机译:腺病毒p53基因治疗鼻咽癌异种移植。

获取原文
获取原文并翻译 | 示例

摘要

Overexpression of the tumor suppressor protein p53 with an adenoviral vector carrying the p53 gene (Ad-p53) has been used successfully in other reports as an anticancer therapeutic in vitro and following intratumoral injection in vivo. Further, this therapeutic strategy has been combined with radiation in animal tumor models, with resultant enhanced radiosensitivity observed. We were interested in examining the impact of Ad-p53 on the radiocurability of nasopharyngeal carcinoma (NPC). Several techniques were used in this thesis to examine the in vivo transduction efficiency achieved following intratumoral injection of an adenoviral vector carrying the lacZ gene (Ad-β-gal). NPC tumor cross-sections and tumor whole mounts were stained with the β-gal substrate X-Gal, and some tumors were stained with the fluorescent β-gal substrate FDG. The results and limitations determined for each technique will be discussed. As well, data from therapeutic experiments combining Ad-p53 and ionizing radiation in NPC xenografts will be presented.
机译:携带 p53 基因的腺病毒载体(Ad- p53 )过表达抑癌蛋白p53已成功用于其他抗癌治疗药物 以及肿瘤内注射后体内。此外,该治疗策略已与动物肿瘤模型中的放射线结合,从而观察到增强的放射敏感性。我们有兴趣检查Ad- p53 对鼻咽癌(NPC)放射线可固化性的影响。本文采用几种技术研究了瘤内注射携带 lacZ 基因(Ad-β-gal)的腺病毒载体后体内的体内转导效率。用β-gal底物X-Gal对NPC肿瘤的横截面和整个肿瘤进行染色,对某些肿瘤用荧光β-gal底物FDG进行染色。将讨论为每种技术确定的结果和局限性。同样,将介绍来自将Ad- p53 和电离辐射结合在NPC异种移植物中的治疗性实验数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号